The Future of AI-Driven Drug Discovery in the United States
The US AI Drug Discovery Market is unveiling a growth trajectory that is expected to reach USD 5,250 million by 2035, driven by a robust CAGR of 25.15%. This expansion signifies a pivotal shift in the pharmaceutical landscape, where artificial intelligence (AI) plays an increasingly vital role in the drug development process. As of 2024, the market is set to stand at approximately USD 211.57...
0 Commentarios 0 Acciones 352 Views 0 Vista previa